MYND Life Sciences Inc.

CNSX:MYND Stock Report

Market Cap: CA$2.4m

MYND Life Sciences Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure3.1yrs
Board average tenure3.8yrs

Recent management updates

Recent updates

Estimating The Intrinsic Value Of MYND Life Sciences Inc. (CSE:MYND)

Jan 13
Estimating The Intrinsic Value Of MYND Life Sciences Inc. (CSE:MYND)

A Look At The Intrinsic Value Of MYND Life Sciences Inc. (CSE:MYND)

Sep 21
A Look At The Intrinsic Value Of MYND Life Sciences Inc. (CSE:MYND)

CEO

MYND Life Sciences has no CEO, or we have no data on them.

Leadership Team

NamePositionTenureCompensationOwnership
Wilfred Jefferies
Co-Founder & Chief Science Officer4.3yrsCA$240.00kno data
Lih-Ming Tam
CFO & Senior Controller3yrsCA$82.08kno data
Chaahat Singh
Senior Operations & Research Manager3.1yrsno datano data
Iryna Saranchova
Chief Clinical Officerno datano datano data

3.1yrs

Average Tenure

Experienced Management: MYND's management team is considered experienced (3.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Mark Geyer
Member of Scientific Advisory Board3.8yrsno datano data
Michael Brownstein
Member of Scientific Advisory Board3.8yrsno datano data
John Campbell
Director4.3yrsno datano data
Roslyn Ritchie-Derrien
Independent Director4.3yrsno datano data
John Trowsdale
Member of Scientific Advisory Board3.8yrsno datano data
Scott Nicoll
Independent Director3.3yrsno datano data
Laurie Bakke
Independent Non Executive Director1.1yrsno datano data
Lana Hoogenboom
Directorless than a yearno datano data

3.8yrs

Average Tenure

Experienced Board: MYND's board of directors are considered experienced (3.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/22 07:24
End of Day Share Price 2025/02/19 00:00
Earnings2024/07/31
Annual Earnings2023/10/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

MYND Life Sciences Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.